| Financial Year |
March 31 2023 |
| Monetary Funds |
235,865,162.93 |
| Held-for-trading Financial Assets |
238,000,000.00 |
| Notes Receivable |
34,329,768.60 |
| Accounts Receivable |
414,067,420.87 |
| Advances to Suppliers |
4,558,184.57 |
| Other Receivables |
1,761,817.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
130,200,418.69 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,034,893.98 |
| Total Current Assets |
1,102,605,934.12 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
101,023,241.79 |
| Under-construction Projects |
49,246,188.71 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
22,603,781.59 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,225,079.98 |
| Deferred Income Tax Assets |
7,654,812.55 |
| Other Non-Current Assets |
43,783,667.21 |
| Sub-Total of Non-Current Assets |
276,282,454.50 |
| Total Assets |
1,378,888,388.62 |
| Short-Term Loans |
20,140,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
91,881,229.48 |
| Accounts Payable |
82,491,122.33 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,137,600.72 |
| Taxes Payable |
5,826,715.86 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
34,167.49 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
684,964.53 |
| Other Current Liabilities |
5,776,392.44 |
| Sub-Total of Current Liabilities |
212,559,826.94 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,513,631.95 |
| Deferred Income Tax Liabilities |
2,188,735.95 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,670,020.87 |
| Total Liabilities |
219,229,847.81 |
| Paid-In Capital(Or Share Stock) |
78,600,000.00 |
| Capital Surplus |
796,495,112.54 |
| Surplus Reserve |
30,515,710.96 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
241,644,880.24 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,159,658,540.81 |
| Owner's Equity（Stockholder's Equity） |
1,159,658,540.81 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,378,888,388.62 |
